- Home
- AQB vs SPRC Comparison
AQB vs SPRC Comparison
Compare AQB & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQB
- SPRC
- Stock Information
- Founded
- AQB 1991
- SPRC 2004
- Country
- AQB United States
- SPRC Israel
- Employees
- AQB N/A
- SPRC N/A
- Industry
- AQB
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- AQB
- SPRC Health Care
- Exchange
- AQB Nasdaq
- SPRC Nasdaq
- Market Cap
- AQB 2.9M
- SPRC 3.0M
- IPO Year
- AQB N/A
- SPRC N/A
- Fundamental
- Price
- AQB $1.18
- SPRC $2.46
- Analyst Decision
- AQB
- SPRC
- Analyst Count
- AQB 0
- SPRC 0
- Target Price
- AQB N/A
- SPRC N/A
- AVG Volume (30 Days)
- AQB 6.1M
- SPRC 931.0K
- Earning Date
- AQB 08-05-2025
- SPRC 01-01-0001
- Dividend Yield
- AQB N/A
- SPRC N/A
- EPS Growth
- AQB N/A
- SPRC N/A
- EPS
- AQB N/A
- SPRC N/A
- Revenue
- AQB N/A
- SPRC $1,306,000.00
- Revenue This Year
- AQB N/A
- SPRC N/A
- Revenue Next Year
- AQB N/A
- SPRC N/A
- P/E Ratio
- AQB N/A
- SPRC N/A
- Revenue Growth
- AQB N/A
- SPRC N/A
- 52 Week Low
- AQB $0.47
- SPRC $2.43
- 52 Week High
- AQB $1.62
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- AQB 78.76
- SPRC 19.36
- Support Level
- AQB $0.74
- SPRC $3.83
- Resistance Level
- AQB $1.60
- SPRC $4.93
- Average True Range (ATR)
- AQB 0.09
- SPRC 0.65
- MACD
- AQB 0.05
- SPRC -0.15
- Stochastic Oscillator
- AQB 53.33
- SPRC 0.93
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.